Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice (PREPARE)

Pfizer

Status and phase: Completed; Phase 4

Conditions: Psoriasis; Psoriatic Arthritis

Treatments: Procedure: lab draws and imaging

Study type: Interventional

Funder types: Industry

Identifiers

NCT01147874

0881A6-4728

B1801032

Details and patient eligibility

About

This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a dermatologist at visit 1 and by a rheumatologist at visit 2. A subset of subjects will then go on to visit 3 for imaging procedures (x-ray, MRI, and ultrasound).

Enrollment: 1,013 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject is >18 years of age at the time of consent.
• Subject has a confirmed diagnosis of plaque psoriasis by clinical judgment.
• Subject is able to read and complete questionnaires.
• Subjects planning to undergo radiographic evaluation, should not have any contraindications to MRI.

Exclusion criteria

• None.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,013 participants in 1 patient group

psoriatic arthritis (PsA) questionnaire

No Intervention group

Treatment:

Procedure: lab draws and imaging